In a closed-door staff briefing, the new boss of the struggling pathology group said the company had not “done a good enough job” of setting up “for success”.
Already a subscriber?The new chief executive of Healius has suggested the pathology group’s former management was “defensive” and made excuses about the company’s poor performance, telling staff a strategic review that could involve asset sales would be finished quickly.
Mr Anderson warned staff to prepare for a substantial amount of “noise” as the company, the country’s second-largest pathology group, came. That work is being done by UBS, and could recommend selling some of its divisions including the flagship Lumus Imaging business. “Whilst the sale of imaging would solve the near-term gearing issue, it wouldn’t solve the profitability and structural challenges faced by the division, which will take years to resolve, in our view.”as chief executive. The company’s former chairwoman, Jenny Macdonald, left the board in November after failing to gain the backing of enough investors for her re-election after the company, once known as Primary Health Care, lost $2 billion in value in two years.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
ASX shares: ASX to open lower, but no end to bull runAustralian shares are expected to open weaker on Monday, after finishing at a record last week. The S&P/ASX 200 has broken intraday records six times this year.
Read more »
CTT ASX: Cettire defends CEO’s $127m share sale ahead of stock slumpDean Mintz offloaded the stake in the luxury retailer after questions were raised about the company’s custom duties. He remains the largest shareholder.
Read more »
WBC shares: ASX quizzes Westpac on persistent speculation of CEO exitThe approach was informal, and came after the bank’s new chairman, Steven Gregg, met with analysts and investors. Westpac downplayed the suggestions.
Read more »
QAN ASX: Peter Costello and Ross McEwan in mix for Qantas board positionsThree directors are leaving the airline this year; two this month. A long list of potential candidates is taking shape, including several high-profile figures.
Read more »
SGH ASX: Ryan Stokes’ Boral bid comes with carrots and a big stickSeven’s bid to buy the rest of Boral comes with several sweeteners, but one big stick that could leave Boral investors in a tough spot.
Read more »
SGR ASX: Star Entertainment faces second Bell inquiry into Sydney casinoThe first independent review of the company’s license to operate in NSW found its operation was “a case study of unethical conduct and cultural failure.
Read more »